Mesoblast (MESO) Assets Average (2017 - 2025)
Mesoblast (MESO) reported Assets Average of $783.5 million for Q4 2025, up 18.49% on a YoY basis from $661.2 million in Q4 2024, and up 8.97% sequentially from $719.0 million in Q2 2025.
Mesoblast (MESO) Assets Average (2017 - 2025) Analysis & Trends
Mesoblast (MESO) has 10 years of Assets Average data on file, last reported at $783.5 million in Q4 2025.
- For the quarter ending Q4 2025, Assets Average rose 18.49% year-over-year to $783.5 million; the trailing twelve-month figure through Dec 2025 stood at $783.5 million (up 18.49% YoY), and the FY2025 full-year result was $726.9 million, up 8.61% from the prior year.
- Assets Average climbed to $783.5 million in Q4 2025, from $719.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $783.5 million in Q4 2025 to a low of $659.3 million in Q1 2023.
- A 5-year average of $697.7 million and a median of $676.3 million in 2022 frame the typical range for Assets Average.
- Across the five-year window, Assets Average fell 11.05% in 2022 and grew 18.49% in 2025, its largest moves.
- Tracing MESO's Assets Average over 5 years: stood at $713.1 million in 2021, then slipped by 5.17% to $676.3 million in 2022, then slipped by 0.95% to $669.8 million in 2023, then decreased by 1.29% to $661.2 million in 2024, then gained by 18.49% to $783.5 million in 2025.
- Business Quant data shows MESO's Assets Average at $783.5 million in Q4 2025, $719.0 million in Q2 2025, and $661.2 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | 783.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 783.50 Mn |
| Jun 30, 2025 | 719.00 Mn |
| Dec 31, 2024 | 661.24 Mn |
| Jun 30, 2024 | 669.72 Mn |
| Dec 31, 2023 | 669.85 Mn |
| Jun 30, 2023 | 659.93 Mn |
| Mar 31, 2023 | 659.25 Mn |
| Dec 31, 2022 | 676.28 Mn |
| Sep 30, 2022 | 673.32 Mn |
| Jun 30, 2022 | 671.92 Mn |
| Mar 31, 2022 | 693.06 Mn |
| Dec 31, 2021 | 713.13 Mn |
| Sep 30, 2021 | 733.27 Mn |
| Jun 30, 2021 | 755.42 Mn |
| Mar 31, 2021 | 726.72 Mn |
| Dec 31, 2020 | 699.94 Mn |
| Sep 30, 2020 | 723.09 Mn |
| Jun 30, 2020 | 699.70 Mn |
| Mar 31, 2020 | 678.01 Mn |
| Dec 31, 2019 | 672.01 Mn |